KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 396-426 in the C-terminal region of human PLAU.
PLAU, a member of the peptidase family S1, is a potent plasminogen activator and is clinically used for therapy of thrombolytic disorders. PLAU specifically cleaves the Arg-|-Val bond in plasminogen to form plasmin. The protein is found in high and low molecular mass forms. Each consists of two chains, A and B. The high molecular mass form contains a long chain A. Cleavage occurs after residue 155 in the low molecular mass form to yield a short A1 chain. The protein is used in Pulmonary Embolism (PE) to initiate fibrinolysis. Structurally, PLAU contains 1 EGF-like domain and 1 kringle domain. Applications: Suitable for use in ELISA, Western Blot, Immunofluorescence, Indirect Flow Cytometry and Immunohistochemistry. Other applications have not been tested. Recommended Dilution: Western Blot: 1:1000 Immunofluorescence: 1:10-1:50 Indirect Flow Cytometry: 1:10-1:50 Immunohistochemistry: 1:10-1:50 Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. .
